Impact Of Trump's Medicaid Drug-Price Proposals Hinges On Follow-Through By CMS, Congress

May 16, 2018
Industry insiders and Medicaid experts are unsure how significantly the President Donald Trump's drug-pricing plan will affect Medicaid drug prices, because it is not clear which of the Medicaid-related proposals CMS or Congress will seriously pursue. Many of the proposals are presented as options the administration may consider or as policy ideas on which the administration is seeking feedback through an HHS request for information . The president's plan and the accompanying request for information indicate the administration is considering...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.